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Abstract 28 
Vitamin B12 is synthesised in the rumen from cobalt and has a major role in metabolism 29 
in the peripaturient period, although few studies have evaluated the effect of the 30 
dietary inclusion of cobalt (Co), vitamin B12 or injecting vitamin B12 on the metabolism, 31 
health and performance of high yielding dairy cows. Fifty-six Holstein-Friesian dairy 32 
cows received one of four treatments from 8 weeks prior to calving to 8 weeks post 33 
calving: C, no added Co; DC, additional 0.2 mg Co/kg DM; DB, additional 0.68 mg 34 
vitamin B12/kg DM; IB, intra-muscular injection of vitamin B12 to supply 0.71 35 
mg/cow/day pre-partum and 1.42 mg/cow/day post-partum. The basal and lactation 36 
rations both contained 0.21 mg Co/kg DM. Cows were weighed and condition scored 37 
at drying off, 4 weeks prior to calving, within 24 h of calving and at 2, 4 and 8 weeks 38 
post-calving, with blood samples collected at drying off, 2 weeks pre-calving, calving 39 
and 2, 4 and 8 weeks post-calving. Liver biopsy samples were collected from all 40 
animals at drying off and 4 weeks post-calving. Live weight changed with time, but 41 
there was no effect of treatment (P>0.05), whereas cows receiving IB had the lowest 42 
mean body condition score and DB the highest (P<0.05). There was no effect of 43 
treatment on post-partum DM intake, milk yield or milk fat concentration (P>0.05) with 44 
mean values of 21.6 kg/day, 39.6 kg/day and 40.4 g/kg respectively. Cows receiving 45 
IB had a higher plasma vitamin B12 concentration than those receiving any of the other 46 
treatments (P<0.001), but there was no effect (P>0.05) of treatment on homocysteine 47 
or succinate concentrations, although mean plasma methylmalonic acid 48 
concentrations were lower (P=0.019) for cows receiving IB than for Control cows. 49 
Plasma β-hydroxybutyrate concentrations increased sharply at calving followed by a 50 
decline, but there was no effect of treatment. Similarly, there was no effect (P>0.05) 51 
of treatment on plasma non-esterified fatty acids or glucose. Whole tract digestibility 52 
of DM and fibre measured at week 7 of lactation were similar between treatments, and 53 
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there was little effect of treatment on the milk fatty acid profile except for C15:0, which 54 
was lower in cows receiving DC than IB (P<0.05). It is concluded that a basal dietary 55 
concentration of 0.21 mg Co/kg DM is sufficient to meet the requirements of high 56 
yielding dairy cows during the transition period, and there is little benefit from additional 57 
Co or vitamin B12. 58 
Key words: dairy cow, digestibility, liver metabolism, milk, minerals    59 
 60 
Implications 61 
The microbes in the rumen of dairy cows require cobalt to synthesise vitamin B12 which 62 
the cows then requires for efficient energy and protein metabolism, particularly during 63 
the transition from pregnancy to early lactation. This study investigated the effect of 64 
feeding different levels of dietary cobalt and supplementing the diet or injecting vitamin 65 
B12, and found little benefit from providing additional amounts on cow performance, 66 
health or milk quality. This information can be used to more accurately formulate diets 67 
for dairy cows to improve health and performance and reduce diet costs.  68 
 69 
Introduction 70 
During the transition period from late gestation to early lactation it is usual for dairy 71 
cows to experience an imbalance between dietary energy intake and nutrient demand 72 
for milk production (Lean et al., 2013; Raboisson et al., 2014). This results in varying 73 
degrees of negative energy balance and consequently mobilisation of body adipose 74 
tissue (Raboisson et al., 2014). The inability of the liver to metabolise mobilised fat 75 
can result in sub-clinical or clinical ketosis, normally defined when plasma β-76 
hydroxybutyrate (3-OHB) concentrations are ≥ 1.2 mmol/L (McArt et al., 2013). The 77 
prevalence of sub-clinical ketosis (SCK) has been reported to be approximately 22% 78 
in European dairy herds (Suthar et al., 2013), whilst in North America a rate of 43% 79 
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has been reported (McArt et al., 2012). Cows with SCK have been reported to have 80 
an increased odds of developing clinical ketosis, displaced abomasum and metritis of 81 
9.5, 5.0 and 1.5 respectively (Suthar et al., 2013), and a decreased probability of 82 
pregnancy (Raboisson et al., 2014).  83 
Vitamin B12 has a major role in the metabolism of lipid by the liver and subsequently 84 
plays a central role in controlling SCK. One of the two main functions of vitamin B12 in 85 
the dairy cow is its action as a co-factor in the transformation of methylmalonyl CoA to 86 
succinyl CoA which is then used in the Krebs cycle within the liver for the synthesis of 87 
glucose from propionate (McDowell 2000). Insufficient tissue supply of vitamin B12 88 
therefore results in an accumulation of methylmalonic acid (MMA) and ketones in the 89 
blood. The second role of vitamin B12 is its requirement as a co-factor for the synthesis 90 
of methionine via the transfer of a methyl group from 5-methyl-tetrahydrofolate to 91 
homocysteine (McDowell 2000). Methionine is generally regarded as one of the first 92 
limiting amino acids in milk protein synthesis (NRC, 2001) and plays a key role in the 93 
synthesis of S-adenosylmethionine as a methyl donor (McDowell 2000), and 94 
consequently has a major impact on milk production.  95 
Within the rumen, elemental cobalt (Co) is used by bacteria to synthesise 96 
vitamin B12, and it has traditionally been considered that the rumen bacteria are able 97 
to synthesise sufficient amounts to meet the cows requirements over the peri-98 
parturient period and throughout lactation, provided there is a sufficient dietary supply 99 
of Co (NRC, 2001). The current recommended level of dietary Co for dairy cows, 100 
based on NRC (2001), is 0.11 mg/kg DM, but vitamin B12 synthesis in the rumen has 101 
been shown to increase linearly between 0.1 and 1.0 mg Co per kg DM (Tiffany et al., 102 
2003; 2006), and growing beef cattle are known to respond to dietary Co levels up to 103 
0.25 mg/kg DM (Stangl et al., 2000). In the well-fed dairy cow, serum vitamin B12 104 
concentrations decline during the dry period and throughout early lactation (Kincaid 105 
5 
and Socha, 2007), but crucially, production and liver-health related responses to 106 
dietary Co spanning current recommended levels have not been determined in the 107 
transition cow, highlighting an area where investigation is required. Additionally, whilst 108 
elemental Co is nontoxic, dietary Co sources have recently been re-classified under 109 
EU legislation (EU 601/2013 amended 2014) as carcinogenic, so that mineral 110 
premixes have been set to contain a maximum of 0.34 mg Co/kg DM. Rumen 111 
protected forms of vitamin B12 are available, but given that vitamin B12 is important in 112 
rumen function, it is questionable if rumen protected sources of vitamin B12 alone are 113 
desirable substitutes for dietary Co. Consequently, there is a need to re-evaluate dairy 114 
cow Co requirements and the benefits of vitamin B12 supplementation over the peri-115 
parturient period in higher yielding dairy cows. The objectives of the study were to 116 
determine the effects of the dietary addition of Co, vitamin B12 or the injection of vitamin 117 
B12 in late gestation/early lactation on dairy cow metabolism, intake and performance. 118 
 119 
Materials and methods  120 
Animals and treatments 121 
Fifty-six Holstein-Friesian dairy cows (12 primiparous and 44 multiparous) 122 
commenced the study 57 (SE ± 0.9) days pre-partum, and remained on study until 56 123 
days post-partum. Cows were blocked according to parity (1st, 2nd and 3rd+), and 124 
previous 305 day milk yield, and randomly allocated to one of four dietary treatments. 125 
Pregnant, non-lactating cows were housed in a free stall-building from the end of 126 
lactation (approximately 8 weeks prior to calving), with ad libitum access to the same 127 
basal dry cow diet which was fed as a total mixed ration (TMR; Table 1) via a barrier 128 
with individual head locks. Approximately 3 days prior to calving the cows were 129 
transferred to a straw bedded calving yard where they remained until approximately 130 
24 h post-calving. For approximately the first 7 to 10 days post-calving cows were 131 
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housed in a loose yard where they had access to a lactation TMR that contained no 132 
added Co via a feed barrier with individual head locks. Cows were then transferred to 133 
free-stall housing containing individual feeders. All cows had continual access to 134 
water. 135 
 Prior to calving the cows received one of four dietary treatments: C = no added 136 
Co; DC = an additional 0.2 mg Co/kg DM (supplied as cobalt carbonate; Anima, 137 
Krakow, Poland); DB = 0.68 mg added vitamin B12/kg DM (Impextraco, Heist-op-den 138 
Burg, Belgium) or IB = injected vitamin B12 (5 ml of 1000 µg vitamin B12/ml resulting in 139 
0.71 mg/day; AnimalCare, York, UK; intra muscular every 7 days). The additional level 140 
of 0.2 mg Co/kg DM in DC was chosen to provide a daily Co supply approximately 141 
twice that of C, but to be within the permitted EU legal limit of 0.34 mg/kg DM. The 142 
0.68 mg vitamin B12/kg DM provided in DB was calculated to provide a similar 143 
predicted tissue supply of vitamin B12 as DC assuming a 4 % conversion of Co to 144 
cobalamin, a loss of 80 % of supplementary vitamin B12 in the rumen, and 10 % 145 
absorption of vitamin B12 at the duodenum (Stemme et al., 2008; Girard et al., 2009; 146 
Akins et al., 2013). The level of injected vitamin B12 was chosen to provide a supra-147 
nutritional tissue supply based on Girard and Matte (2005a), and therefore act as a 148 
positive control. All animals were individually supplemented with 200 g/day of ground 149 
wheat which acted as a carrier for treatments DC and DB by restraining each cow 150 
using the individual head-lock gates until the daily allowance had been consumed, and 151 
assuming a DM intake of 12 kg/cow/day (NRC, 2001).  152 
From calving until approximately 8-10 days post-calving all cows were fed a TMR 153 
(Table 1) containing no additional Co or vitamin B12. During this period all animals 154 
were supplemented with 200 g/day of ground wheat as a carrier to provide treatments 155 
DC and DB, assuming a DM intake of approximately 20 kg/day (NRC 2001), with IB 156 
receiving 10 ml of 1000 µg vitamin B12/ml injected every 7 days, resulting in 1.42 157 
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mg/day. For the remainder of the study the supplements were included into the TMR, 158 
and intake monitored using roughage intake feeders (Hokofarm, Marknesse, The 159 
Netherlands).  160 
Experimental routine 161 
The cows were weighed and condition scored (Ferguson et al., 1994) at drying off, 4 162 
weeks post-drying off, within 24 h of calving, and at weeks 2, 4 and 8 post-calving. 163 
Samples of the TMR and individual forages were collected weekly: the forage sample 164 
was oven dried and the quantity of lucerne and maize silage adjusted to achieve the 165 
desired ratio, and the TMR sample frozen at -20°C prior to analysis. Blood samples 166 
were collected by jugular venepuncture at 1000 h on the day of drying off, 6 weeks 167 
post-drying (approximately 2 weeks prior to calving), within 24 h of calving, and 2, 4 168 
and 8 weeks post calving. Liver samples were collected by biopsy through the 11th 169 
intercostal space from all animals at drying off and at 4 weeks post-calving; samples 170 
were snap frozen in liquid N and stored at -80°C until subsequent analysis. Cows were 171 
milked twice daily at approximately 0600 and 1700 h, with yield recorded at each 172 
milking, and samples taken weekly on consecutive am and pm milkings for subsequent 173 
analysis. Additional milk samples were collected during week 7 of lactation for the 174 
determination of the fatty acid (FA) profile. Whole tract digestibility was estimated 175 
during week 7 of lactation by collecting faecal samples from each cow over 5 days at 176 
approximately 0800 and 1400 h (Van Keulen and Young, 1977), and stored at -20°C 177 
for subsequent analysis. 178 
Chemical analysis 179 
Weekly TMR samples were bulked within month and analysed according to AOAC 180 
(2012) for DM (934.01) and CP (988.05), whilst NDF and ADF were determined 181 
according to Van Soest et al. (1991). The determination of NDF was conducted without 182 
sodium sulphite, with alpha-amylase and was corrected for ash. Samples were also 183 
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analysed for major and trace minerals as described by Cope et al. (2009). Plasma 184 
samples were analysed for urea, glucose, non-esterified fatty acids and 3-185 
OHB (Randox Laboratories, County Antrim, UK; kit catalogue no.  TP245, UR221, 186 
AB362, GL1611, FA115 and RB 1008 with an intra-assay CV of 3.5, 1.8, 3.0 and 4.7% 187 
respectively) using a Cobas Miras Plus auto-analyser (ABX Diagnostics, Bedfordshire, 188 
UK). Plasma samples were analysed for minerals as described by Cope et al. (2009). 189 
Analysis of plasma vitamin B12, homocysteine, MMA, succinic acid (SA) and hepatic 190 
triacylglycerol (TAG) concentration (along with their intra-assay CV) are provided in 191 
Supplementary Material S1. For MMA and SA only the two most extreme treatments 192 
(C and IB) were analysed. Milk samples were analysed for fat, protein, lactose and 193 
somatic cell count by Eurofins UK (Wolverhampton, UK). Fatty acid methyl esters 194 
(FAME) in hexane were prepared from milk fat and individual FAME were determined 195 
by GLC (Hewlett Packard 6890, Wokingham, UK) fitted with a CP-Sil 88 column (100 196 
m x 0.25 mm i.d. x 0.2 μm film) as described previously by Sinclair et al., (2015). 197 
Faecal samples were bulked between days and sampling times and analysed for acid 198 
insoluble ash (Van Keulen and Young 1977), ash (AOAC, 2012; 942.05), CP, NDF 199 
and ADF.  200 
Statistical analysis 201 
Performance and blood parameters were analysed as repeated measures 202 
analysis of variance, using Genstat 17.1 (VSN Int. Ltd., Oxford, UK). The performance 203 
in the week prior to allocation was used as a co-variate where appropriate:  204 
Yijk = µ + Bi + Cj + Tk + Cj.Tl  + εijk 205 
Where Yijk = dependent variable; µ = overall mean; Bi = fixed effect of blocks; Cj = 206 
effect of treatment; Tk = effect of time; Cj.Tk = interaction between treatment and time, 207 
and εijk = residual error. Milk SCC and hepatic TAG concentrations were log 208 
transformed prior to analysis to homogenise variance. A subsequent analysis of TAG 209 
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levels substituted parity for treatment. Milk FA concentration and diet digestibility were 210 
analysed as a randomised block design by analysis of variance as:  211 
Yij = µ + Bi + Cj + εij 212 
Where Yij = dependent variable; µ = overall mean; Bi = fixed effect of blocks; Cj = 213 
effect of treatment, and εij = residual error. Results are presented as treatment 214 
means with a SED, with post-hoc analysis using Tukey’s test at a 5% level of 215 
significance. 216 
 217 
Results 218 
Diet analysis, intake and animal performance. 219 
The chemical composition of the basal dry-cow diet was similar to that predicted, 220 
whereas the background concentration of Co was higher in both the dry cow and 221 
lactation diets at 0.21 mg/kg DM (Table 2). The four lactation diets had a similar mean 222 
DM, OM, CP, NDF and ADF concentration of 469 g DM/kg, 940, 168, 368 and 231 223 
g/kg DM respectively. The four diets also had a similar concentration of macro and 224 
trace elements. In contrast, the treatments with no added Co (C, and IB) had a dietary 225 
concentration of approximately 0.21 mg Co/kg DM, whilst DC had almost double the 226 
dietary concentration of Co, with DB being 0.02 mg Co/kg DM higher than the Control.  227 
 There was an increase in DM intake (P<0.001) from 18.6 kg/d during week 2 of 228 
lactation to 23.7 kg/d during week 8, with a mean intake of 21.6 kg/d over the study 229 
period, but there was no effect (P>0.05) of dietary treatment or treatment x time 230 
interaction (Table 3). Similarly, milk yield increased (P<0.001) from 30.3 kg/d in week 231 
1 to 43.6 kg/d in week 8 of lactation, but there was no effect (P>0.05) of treatment or 232 
time x treatment interaction on milk performance or composition, with mean values of 233 
39.6 kg/day, 40.4 g/kg and 33.1 g/kg for milk yield, fat and protein concentration 234 
respectively. There was an effect of time (P<0.001) on live weight, which increased 235 
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between drying off and 4 weeks pre-calving, before decreasing immediately post-236 
calving but there was no effect (P>0.05) of treatment, or time x treatment interaction. 237 
There was also an effect of time on BCS (P<0.001), which declined post-calving, and 238 
treatment, with cows receiving IB having the lowest and DB the highest BCS (P<0.05). 239 
Plasma metabolite and mineral concentrations, and hepatic triacylglycerol content  240 
Plasma glucose concentration decreased from 8 weeks pre-calving to calving, then 241 
increased to week 8 post calving (P<0.001), but there was no effect (P>0.05) of dietary 242 
treatment on weekly or mean concentration (Table 4 and Supplementary Figure 1a). 243 
In contrast, plasma 3-OHB concentrations increased pre-calving, with a sharp 244 
increase at calving followed by a decrease at week 2 of lactation (Supplementary 245 
Figure 1b), but there was no effect (P>0.05) of dietary treatment. There was an effect 246 
of time on plasma NEFA concentration (Supplementary Figure 1c; P<0.001), which 247 
decreased pre-calving, before increasing post-calving, but there was no effect 248 
(P>0.05) of treatment. Plasma urea concentrations declined rapidly at calving 249 
(Supplementary Figure 1d; P<0.001) but were not affected (P>0.05) by treatment. 250 
There was no effect (P>0.05) of dietary treatment on mean plasma mineral 251 
concentration, except Co, which was higher (P<0.05) in cows receiving DC or IB than 252 
C or DB, and Zn, which was higher in cows receiving DC than IB (P<0.05).  253 
There was a treatment x time interaction (P<0.001) for plasma vitamin B12 254 
concentration, which decreased post calving in all treatments (Figure 1a), and overall 255 
was higher (P<0.001) in cows receiving IB than any of the other treatment groups (246 256 
vs 192, 195 and 190 pmol/L for IB vs C, DC and DB respectively). There was no 257 
treatment effect on plasma concentrations of homocysteine, which decreased 258 
(P<0.001) following calving (Figure 1b). In contrast, plasma concentrations of both 259 
MMA (Figure 1c) and SA (Figure 1d) increased (P<0.001) following parturition, with 260 
an interaction between treatment and time for plasma MMA concentrations (P=0.033); 261 
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MMA being lower in IB than Control cows post-calving. There was no treatment effect 262 
on hepatic TAG concentrations pre- or post-partum (P>0.05), however, TAG 263 
concentrations were higher (P<0.001) in samples collected during the early post-264 
partum period than during late gestation. 265 
Diet digestibility and milk fatty acid profile 266 
There was no effect (P>0.05) of dietary treatment on the digestibility of any of the 267 
parameters measured (P>0.05; Table 5). There were few differences in the FA profile 268 
of milk from cows fed any of the treatments, except C15:0 which was lower (P<0.05) 269 
in cows receiving supplementary Co (DC) compared to injected vitamin B12 (IB; Table 270 
6). The desaturase index calculated using cis-9, trans-11 CLA was lower (P<0.01) in 271 
cows receiving IB compared to C or DC, but there was no other effect of dietary 272 
treatment.   273 
 274 
Discussion 275 
To attempt to provide a low dietary Co concentration in the current study, feed 276 
ingredients were selected to be low in Co, with the mineral/vitamin supplement 277 
formulated to contain no Co.  Despite this, both the dry cow and lactation control diets 278 
contained 0.21 mg Co/kg DM, above the recommended dietary requirement of 0.11 279 
mg/kg DM stated by NRC (2001), but considerably lower than a number of similar 280 
studies that have attempted to provide low dietary Co diets (Akins et al., 2013; Girard 281 
et al., 2009). The addition of 0.2 mg Co/kg DM in DC resulted in a dietary concentration 282 
approximately twice that of C, but was well within the permitted EU legal limit of 0.34 283 
mg added Co/kg DM, or the 1.14 mg Co/kg DM limit in the total diet.  284 
Performance and dry matter intake 285 
The peri-parturient period in dairy cows is characterised by a phase of negative energy 286 
balance as cows transition from late gestation into early lactation, with associated 287 
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homeorhetic and homeostatic regulation of metabolic functions (McArt et al., 2013). In 288 
particular, there is a substantial increase in demand for glucose for foetal growth in 289 
late pregnancy, and for the synthesis of lactose for milk production by the mammary 290 
gland in early lactation (Lean et al., 2013). Vitamin B12, through its role as a co-enzyme 291 
for methylmalonyl-CoA mutase (EC:5.4.99.2), is crucial for the synthesis of glucose 292 
from propionate (McDowell, 2000), and a deficiency in this vitamin can be translated 293 
into a reduction in milk synthesis (NRC, 2001). Milk secretion also requires a 294 
considerable supply of amino acids, with methionine generally being regarded as one 295 
of the first rate limiting AA in most dairy cow rations (NRC, 2001), and vitamin B12 has 296 
a key role in the activity of methionine synthase (EC:2.1.1.13) which regenerates 297 
homocysteine to methionine (McDowell 2000). In the current study, additional dietary 298 
Co or vitamin B12 or parenteral supply of vitamin B12 did not influence milk production 299 
or composition in early lactation. Similarly, Kincaid and Socha (2007) reported no 300 
effect of dietary Co concentration (0.15, 0.89 and 1.71 mg/kg DM) on early lactation 301 
milk yield or composition. In contrast, Juchem et al., (2012) reported a decrease in 302 
milk fat concentration, but not fat yield, when rumen protected B-vitamins were 303 
included in dairy cow rations, although the combination of vitamins used precludes 304 
any conclusion to be drawn on the relative efficacy of vitamin B12. Duplessis et al., 305 
(2017) also reported no effect of weekly injections of 10 mg of vitamin B12 on milk 306 
performance or composition over the transition period. Weekly intramuscular 307 
injections of vitamin B12, however, resulted in a significant increase in energy corrected 308 
milk yield of early lactation primiparous dairy cows supplemented with folic acid and 309 
methionine in the study of Girard and Matte (2005a), due to a combination of an 310 
increase in milk yield and milk fat concentration, despite dietary Co levels being stated 311 
as adequate. In contrast, NRC (2001) concluded that there was no evidence of a 312 
performance response to vitamin B12 injections in dairy cows when fed adequate (i.e. 313 
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above 0.11 mg/kg DM) amounts of Co. Results from the current study support that the 314 
recent EU restriction on the amount of supplementary Co that can be added to the diet 315 
should not impair dairy cow performance or health. There may, however, be some 316 
value to higher dietary levels of Co, or rumen protected vitamin B12 to increase the 317 
vitamin B12 content in milk for human consumption as suggested by Girard and Matte 318 
(2005b), particularly in situations where foods are fortified with folic acid. 319 
Regulation of lipogenesis and lipolysis in the transition period involves a 320 
complex interaction between neural, hormonal and paracrine stimuli, along with 321 
immune cell migration that changes the structure and cellular distribution of adipose 322 
tissue (Contreras et al., 2017). In the current study, both live weight and body condition 323 
score were characterised by an increase pre-partum, followed by a rapid decline post-324 
partum, reaching a nadir at approximately 4 weeks post-calving. This rapid decline in 325 
body condition and live weight is greater than that reported in other studies that have 326 
investigated the effect of diet on body energy reserves where the nadir in energy 327 
balance is typically not reached until approximately week 8 to 10 post-partum 328 
(Duplessis et al., 2017). Parenteral administration of vitamin B12 resulted in the lowest 329 
mean BCS post-partum, but this was not reflected in an increase in milk or milk fat 330 
yield. Duplessis et al. (2017) reported no benefit to injections of vitamin B12 on body 331 
condition over the transition period, although dietary levels of Co (1.45 and 1.05 mg/kg 332 
DM for the dry period and lactation respectively) were substantially higher than that 333 
used here.  334 
Cows fed any of the dietary treatments in the current study continued to 335 
increase their DM intake throughout the first 8 weeks of lactation, but there was no 336 
effect of dietary Co level or vitamin B12 on intake. Several other studies have also failed 337 
to demonstrate a benefit to Co supplementation or parenteral administration of vitamin 338 
B12 on DM intake either pre-partum or during lactation (Akins et al., 2013; Girard and 339 
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Matte, 2005a). Indeed, supra-nutritional levels of Co have been demonstrated to result 340 
in a reduction in DM intake in some studies, particularly in early lactation (Kincaid and 341 
Socha, 2007).  342 
Blood metabolites, minerals and hepatic triacylglycerol content 343 
Poor adaptation to negative energy balance through the transition period is associated 344 
with an elevation in plasma NEFA and 3-OHB concentrations (McArt et al., 2013). 345 
Whilst there is much debate regarding definitive cut-point concentrations of these 346 
metabolites for milk production and disease outcomes, NEFA values of 0.3 to 0.5 347 
mmol/l pre-partum and 0.7 to 1.0 mmol/l post partum, and 3-OHB concentrations of 348 
1.2 mmol/l, have been suggested as a good combination between sensitivity and 349 
specificity (McArt et al., 2013). Based on these assumptions, mean plasma NEFA in 350 
the current study were high at drying off and again at calving, whereas mean plasma 351 
3-OHB concentrations were always well within accepted limits. Plasma glucose 352 
concentrations were also affected by day of sampling in the current study, decreasing 353 
sharply at 2 weeks post-calving before returning to pre-partum levels by week 4. There 354 
was, however, no effect of dietary treatment on any of these metabolites pre or post-355 
partum, and it is apparent that vitamin B12 was not limiting for cows. A number of other 356 
studies have also reported no effect of dietary Co level (Akins et al., 2013; Kincaid and 357 
Socha, 2007), dietary supplementation with vitamin B12 (Graulet et al., 2007) or 358 
following parenteral administration of vitamin B12 (Akins et al., 2013; Duplessis et al., 359 
2017) on serum NEFA concentration.  360 
A threshold for plasma vitamin B12 of 150 µmol/l has been suggested, above 361 
which there is little further benefit to milk performance in dairy cows (Duplessis et al., 362 
2017). Plasma vitamin B12 in the current study was above this threshold in cows fed 363 
any of the dietary treatments, and were approximately 28% higher in cows receiving 364 
weekly injections of vitamin B12. The high demands for metabolism and secretion into 365 
15 
milk (Kincaid and Socha 2007) may predispose higher yielding dairy cows to vitamin 366 
B12 deficiency and can be exhibited in an increase in plasma concentrations of key 367 
intermediaries in energy and amino acid metabolism. The dependency of methionine 368 
synthase and methylmalonyl-CoA mutase on vitamin B12 results in plasma 369 
concentrations of homocysteine and MMA acid being good indicators of vitamin B12 370 
adequacy (Stangl et al., 2000). These authors reported a significant decline in both 371 
plasma homocysteine and MMA when dietary Co concentrations were increased 372 
above 0.2 mg/kg DM in growing beef cattle. However, in the current study there was 373 
little effect of supplementary Co, vitamin B12 or parental administration of vitamin B12, 374 
and supports the performance and blood metabolite results that the basal dietary Co 375 
concentration of 0.21 mg/kg DM was sufficient to meet requirements in late pregnancy 376 
and early lactation. Despite the lack of an effect of treatment on hepatic TAG 377 
concentrations in the current study there was a 3-fold increase in concentration post- 378 
compared to pre-partum (mean values of 19 and 6 mg/g liver respectively), although 379 
mean values were still within the 1-5% liver TAG concentration that is associated with 380 
mild fatty liver (Bobe et al., 2004). 381 
Whole tract digestibility 382 
In addition to the requirement for the metabolism of glucose and methionine in the 383 
dairy cow, vitamin B12 has been demonstrated to be an essential growth factor for 384 
efficient rumen microbial metabolism, with ruminal synthesis of vitamin B12 and 385 
subsequent flow to the duodenum being significantly related to the rate of microbial 386 
protein synthesis in the rumen (Castagnino et al., 2016). This has been suggested to 387 
improve fibre digestion in the rumen (Lopez Guisa and Satter, 1992), and increase the 388 
ruminal production of propionate in some studies (Tiffany et al., 2003), but not others 389 
(Stemme et al., 2008). Increasing dietary Co concentration from sub-optimal levels 390 
has been shown to increase whole tract digestibility quadratically in sheep, being 391 
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highest at a dietary level of 0.6 mg/kg DM (Wang et al., 2007). Similarly, Kadim et al. 392 
(2003) reported that the parental provision of vitamin B12 increased diet digestibility in 393 
goats, which was speculated to be due to an increase in intestinal absorption of 394 
nutrients or microbial production in the rumen. In the current study digestibility co-395 
efficients for DM, N, OM and fibre fractions were similar to that reported by others 396 
when feeding similar diets (Sinclair et al., 2015), but there was no effect of dietary 397 
treatment, and it can be concluded that there was sufficient vitamin B12 available for 398 
ruminal metabolism.  399 
Milk fatty acids 400 
The concentration of saturated FA in milk may be reduced via the action of steroyl-401 
CoA desaturase (SCD) on both de novo and absorbed FA such as C14:0, C16:0 and 402 
C18:0, and is responsible for the majority of the cis-9, trans-11 CLA from its action on 403 
C18:1 trans-11 (Shingfield et al., 2013). Several studies have investigated the impact 404 
of the dietary inclusion, ruminal infusion or intravenous injection of Co on SCD activity, 405 
and reported a dose dependent decrease in activity by up to 72% (Leskinen et al., 406 
2016). Infusing Co does not impact on gene expression of SCD, and its effects would 407 
therefore appear to be at a post-transcriptional level (Karlengen et al., 2012). However, 408 
in previous studies that have reported a reduction in SCD activity supra-nutritional 409 
levels of Co have been fed. For example, Karlengen et al. (2012) reported no effect 410 
on the milk desaturase index in cows when fed approximately 0.2 or 19 mg Co/kg DM, 411 
but it was reduced when 270 mg/kg DM was infused into the rumen.  In the current 412 
study, there was little evidence of an effect of adding approximately 0.2 mg Co/kg DM, 413 
or additional vitamin B12 administered per os, on SCD activity. In contrast, SCD activity 414 
was reduced when supra-nutritional levels of vitamin B12 were injected, although few 415 
other studies have examined the effect of vitamin B12 on the activity of this enzyme.  416 
 417 
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Conclusions 418 
A dietary Co concentration of 0.21 mg/kg DM provides sufficient Co for the synthesis 419 
of vitamin B12 required for the metabolism, performance and diet digestibility of high-420 
yielding dairy cows. Recent restrictions on the inclusion of Co in the diet in the 421 
European Union are therefore unlikely to have an impact on intake, performance or 422 
health over the periparturient period, and there is little justification for the use of 423 
supplementary sources of vitamin B12. 424 
 425 
Acknowledgements 426 
The authors would like to acknowledge the input of Jess Marshall, Paul Daley, Rosie 427 
Barraclough and Marcus Doig for assistance with collecting and analysing the 428 
samples, and to AHDB Dairy for funding the study. WADV Weerathilake was 429 
supported by a Commonwealth Studentship, and AH Brassington by a scholarship 430 
from The Perry Foundation.   431 
 432 
Declaration of interest  433 
None 434 
 435 
Ethics Statement 436 
The procedures involving animals were conducted in accordance with the UK Animals 437 
(Scientific Procedures) Act 1986 (amended 2012), and were approved by the Harper 438 
Adams University Local Ethical Review. 439 
 440 
Software and data repository resources  441 
None. 442 
 443 
18 
References 444 
Akins MS, Bertics SJ, Socha MT and Shaver RD 2013. Effects of cobalt supplementation 445 
and vitamin B12 injections on lactation performance and metabolism of Holstein dairy cows. 446 
Journal of Dairy Science 96, 1755-1768. 447 
Association of Analytical Chemists (AOAC) 2012. Official methods of analysis, volume 1, 448 
19th edition, AOAC, Arlington, VA, USA. 449 
Bobe G, Young JW and Beitz DC 2004. Invited review: pathology, etiology, prevention, and 450 
treatment of fatty liver in dairy cows. Journal of Dairy Science 87, 3105-3124. 451 
Castagnino DS, Seck M, Beaudet V, Kammes KL, Voelker Linton JA, Allen MS, Gervais R, 452 
Chouinard PY and Girard CL 2016. Effects of forage family on apparent ruminal synthesis of 453 
B vitamins in lactating dairy cows. Journal of Dairy Science 99, 1884-1894. 454 
Contreras GA, Strieder-Barboza C and Raphael W 2017. Adipose tissue lipolysis and 455 
remodelling during the transition period of dairy cows. Journal of Animal Science and 456 
Biotechnology 8, 41. 457 
Cope CM, Mackenzie AM, Wilde D and Sinclair LA 2009. Effects of level and form of dietary 458 
zinc on dairy cow performance and health. Journal of Dairy Science 92, 2128-2135. 459 
Duplessis M, Lapierre H, Pellerin D, Laforest JP and Girard CL 2017. Effects of intramuscular 460 
injections of folic acid, vitamin B12, or both, on lactational performance and energy status of 461 
multiparous dairy cows. Journal of Dairy Science100, 4051-4064. 462 
Ferguson JD, Galligan DT, and Thomsen N 1994. Principal descriptors of body condition score 463 
in Holstein cows. Journal of Dairy Science 77, 2695-2703. 464 
Girard CL, Santschi DE, Stabler SP and Allen RH 2009. Apparent ruminal synthesis and 465 
intestinal disappearance of vitamin B12 and its analogs in dairy cows. Journal of Dairy Science 466 
92, 4524-4529. 467 
19 
Girard CL and Matte JJ 2005a. Effects of intramuscular injections of vitamin B12 on lactation 468 
performance of dairy cows fed dietary supplements of folic acid and rumen-protected 469 
methionine. Journal of Dairy Science 88, 671-676.  470 
Girard Cl and Matte JJ 2005b. Folic acid and vitamin B12 requirements of dairy cows: A concept 471 
to be revised. Livestock Production Science 98, 123-133. 472 
Graulet B, Matte JJ, Desrochers A, Doepel L, Palin MF and Girard CL 2007. Effects of dietary 473 
supplements of folic acid and vitamin B12 on metabolism of dairy cows in early lactation. 474 
Journal of Dairy Science 90, 3442-3455. 475 
Juchem SO, Robinson PH and Evans E 2012. A fat based rumen protection technology post-476 
ruminally delivers a B vitamin complex to impact performance of multiparous Holstein cows. 477 
Animal Feed Science and Technology 174, 68-78. 478 
Kadim IT, Johnson EH, Mahgoub O, Srikandakumar A, Al-Ajmi D, Ritchie A, Annamalai K and 479 
Al-Halhali AS 2003. Effect of low levels of dietary cobalt on apparent nutrient digestibility in 480 
Omani goats. Animal Feed Science and Technology 109, 209-216. 481 
Kanakkaparambil R, Singh R, Li D, Webb R and Sinclair KD 2009. B-vitamin and 482 
homocysteine status determines ovarian response to gonadotrophin treatment in sheep. 483 
Biology of Reproduction 80, 743-752.     484 
Karlengen IJ, Harstad OM, Taugbøl O, Berget I, Aastveit AH and Våge DI 2012. The effect 485 
of excess cobalt on milk fatty acid profiles and transcriptional regulation of SCD, FASN, 486 
DGAT1 and DGAT2 in the mammary gland of lactating dairy cows. Journal of Animal 487 
Physiology and Animal Nutrition. 96 1065-1073. 488 
Kincaid RL and Socha MT 2007. Effect of cobalt supplementation during late gestation and 489 
early lactation on milk and serum measures. Journal of Dairy Science 90, 1880-1886. 490 
20 
Lean IJ, Van Saun R and DeGaris PJ 2013. Energy and protein nutrition management of 491 
transition dairy cows. Veterinary Clinics Food Animal Practice 29, 337–366.  492 
Leskinen H, Viitala S, Mutikainen M, Kairenius Piia, Tapio I, Taponen J, Bernard L, Vilkki J 493 
and Shingfield KJ 2016. Ruminal infusions of cobalt EDTA modify milk fatty acid composition 494 
via decreases in fatty acid desaturation and altered gene expression in the mammary gland 495 
of lactating cows. Journal of Nutrition 146, 976-985. 496 
Lopez-Guisa JM and Satter LD 1992. Effect of copper and cobalt addition on digestion and 497 
growth in heifers fed diets containing alfalfa silage or corn crop residues. Journal of Dairy 498 
Science 75, 247-256. 499 
McArt JAA, Nydam DV and Oetzel GR 2012. Epidemiology of subclinical ketosis in early 500 
lactation dairy cattle. Journal of Dairy Science 95, 5056-5066. 501 
McArt JAA, Nydam DV, Oetzel GR, Overton TR and Ospina PA 2013. Elevated non-esterified 502 
fatty acids and ß-hydroxybutyrate and their association with transition dairy cow performance. 503 
The Veterinary Journal 198, 560-570. 504 
McDowell LR 2000. Vitamins in animal and human nutrition, 2nd edition. Iowa State University 505 
Press, Ames, IA, USA.  506 
National Research Council (NRC) 2001. Nutrient requirements of dairy cattle. 7th revised 507 
edition. National Academy Press.  508 
Preynat A, Lapierre H, Thivierge MC, Palin MF, Matte JJ Desrochers A and Girard CL 2009. 509 
Effects of supplements of folic acid, vitamin B12, and rumen-protected methionine on whole 510 
body metabolism of methionine and glucose in lactating cows. Journal of Dairy Science 92, 511 
677-689. 512 
21 
Raboisson D, Mounié M and Maigné E 2014. Diseases, reproductive performance, and 513 
changes in milk production associated with subclinical ketosis in dairy cows: A meta-analysis 514 
and review. Journal of Dairy Science 97, 7547-7563. 515 
Shingfield KJ, Arölä A, Ahenjärvi S, Vanhatalo A, Toivonen V, Griinari JM and Huhtanen P 516 
2013. Ruminal infusions of cobalt-EDTA reduce mammary ∆9-desturase index and later milk 517 
fatty acid composition in lactating dairy cows. The Journal of Nutrition 138, 710-717. 518 
Sinclair LA, Edwards R, Errington KA, Holdcroft AM and Wright M 2015. Replacement of 519 
grass and maize silages with lucerne silage: effects on performance, milk fatty acid profile 520 
and digestibility in Holstein-Friesian dairy cows. Animal 9: 1970-1978. 521 
Stangl GJ, Schwarz FJ, Müller H and Kirchgessner M 2000. Evaluation of the cobalt 522 
requirement of beef cattle based on vitamin B12, folate, homocysteine and methylmalonic 523 
acid. British Journal of Nutrition 84, 645-653.  524 
Stemme K, Lebzien P, Flachowsky G and Scholz H 2008. The influence of an 525 
increased cobalt supply on ruminal parameters and microbial vitamin B12 synthesis in 526 
the rumen of dairy cows. Archives of Animal Nutrition 62, 207-218. 527 
Suthar VS, Canelas-Raposo J, Deniz A and Heuwieser W 2013. Prevelance of subclinical 528 
ketosis and relationships with postpartum diseases in European dairy cows. Journal of Dairy 529 
Science 96, 2925-2938. 530 
Tiffany ME, Spears JW, Xi L and Horton J 2003. Influence of supplemental cobalt source 531 
and concentration on performance, vitamin B12 status, and ruminal and plasma metabolites 532 
in growing and finishing steers. Journal of Animal Science 81, 3151-3159. 533 
Tiffany ME, Fellner V and Spears JW 2006. Influence of cobalt concentration on vitamin B12 534 
production and fermentation of mixed ruminal microorganisms grown in continuous culture 535 
flow-through fermentors. Journal of Animal Science 84, 635-640. 536 
22 
Van Keulen J and Young BA 1977. Evaluation of acid-insoluble ash as a natural marker in 537 
ruminant digestibility studies. Journal of Animal Science 44, 282-287. 538 
Van Soest PJ, Robertson JB and Lewis BA 1991. Methods for dietary fiber, neutral detergent 539 
fiber, and nonstarch polysaccharides in relation to animal nutrition.  Journal of Dairy Science 540 
74, 3583-3597. 541 
Wang RL, Hong XH, Zhang YZ, Zhu XP, Narenbatu and Jia ZH 2007. Influence of dietary 542 
cobalt on performance, nutrient digestibility and plasma metabolites in lambs. Animal Feed 543 
Science and Technology 135, 346-352. 544 
23 
 
 
 
 
 
 
Table 1 Basal dry cow and lactation total mixed ration composition  
 Dry cow1 Lactation 
Ingredient, g/kg DM 
  Chopped wheat straw 
 
471 
 
--- 
  Maize silage 218 389 
  Lucerne silage 87 111 
  Wheat 109 79 
  Molassed sugar beet feed --- 79 
  Soy hulls --- 66 
  Molasses 3 7 
  Protected fat --- 16 
  Rapeseed meal 31 91 
  Corn gluten feed 26 76 
  Hipro soybean meal 19 55 
  Palm kernel meal 9 25 
  Feed grade urea 10 1 
  Dry cow minerals2 13 --- 
  Lactation minerals3 --- 5 
  Magnesium chloride 4 --- 
1Water was added at 0.43 kg/kg DM 
2Dry cow minerals g/kg: Ca 20; P 60; Mg 200; Na 5; mg/kg I 400; 
Se 30; Cu 750; Mn 4 000; Zn 6 000; iu/kg Vit A 800 000; Vit D 200 
000; Vit E 10 000; Biotin 75 mg/kg.  
3Lactation minerals g/kg: Ca 180; P 25; Mg 80; Na 120; mg/kg I 
400; Se 40; Cu 1 400; Mn 4 000; Zn 6 000; iu/kg Vit A 1 000 000; 
Vit D 300 000; Vit E 4 500; Biotin 135 mg/kg. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
24 
 
 
 
Table 2 Chemical and mineral composition of dry cow and lactation diets that 
contained no added cobalt (C), added dietary Co (DC), added dietary vitamin 
B12 (DB) or injected vitamin B12 (IB)
Nutrient Dry cow1 C and IB DC DB 
DM, g/kg 474 471 466 468 
Organic matter, g/kg DM 932 941 939 937 
Ash, g/kg DM 67.8 59.2 60.9 63.1 
CP, g/kg DM 139 168 169 165 
NDF, g/kg DM 561 364 359 386 
ADF, g/kg DM 359 230 226 238 
Hemicellulose, g/kg DM 202 134 133 148 
Fat, g/kg DM 16.7 33.5 34.4 31.7 
Fatty acids, g/100 g FA     
     C16:0 25.1 25.9 24.1 25.9 
     C18:0 nd2 2.10 1.99 2.10 
     C18:2 cis-9, cis-12 28.5 27.5 27.1 27.5 
     C18:3 cis-9, cis-12, cis-15 3.15 2.69 2.44 2.69 
Macro minerals, g/kg DM   
      Ca 5.82 7.84 7.71 7.87 
      P 2.92 4.03 4.15 4.05 
      Mg 4.25 2.69 2.71 2.74 
      Na 1.32 1.66 1.66 1.66 
      K 12.8 15.7 15.8 15.9 
      S 1.77 2.50 2.50 2.32 
Micro minerals, mg/kg DM   
     Co 0.21 0.21 0.36 0.23 
     Mn 76.0 58.9 57.2 59.4 
     Fe 279 281 274 285 
     Zn 102 67.1 64.0 65.6 
     Mo 1.34 1.16 1.20 1.48 
1Dry cow treatments achieved by individually providing either no added Co (C), 
0.2 mg Co/kg DM (DC), 0.68 mg vitamin B12/kg DM (DB) or injected vitamin B12 
(IB).  
2nd = not detected 
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Table 3 Intake (post calving), milk performance and body condition (mean value pre- and 
post-calving) of dairy cows offered diets that contained no added cobalt (C), added dietary 
Co (DC), added dietary vitamin B12 (DB) or injected vitamin B12 (IB)
 Treatment P-value1 
 C DC DB IB SED Treatment Time
DM intake (kg/day) 21.5 21.3 21.7 21.8 0.78 0.918 <0.001 
Milk yield (kg/day) 38.3 39.5 40.8 39.6 1.58 0.480 <0.001 
Milk fat (g/kg) 40.6 40.8 40.6 39.6 1.92 0.922 <0.001 
Milk protein (g/kg) 32.9 33.2 33.3 33.1 0.67 0.936 <0.001 
Milk lactose (g/kg) 45.0 45.0 45.4 45.0 0.37 0.668 <0.001 
Milk fat (kg/d) 1.54 1.59 1.63 1.55 0.921 0.715 0.035 
Milk protein (kg/d) 1.24 1.28 1.34 1.30 0.046 0.235 <0.001 
Milk lactose (kg/d) 1.72 1.75 1.86 1.79 0.073 0.256 <0.001 
SCC (log10/ml)2 1.74 1.59 1.67 1.83 0.152 0.452 <0.001 
Body condition 3.00ab 3.08ab 3.14b 2.94a 0.069 0.042 <0.001 
Live weight (kg) 665 657 683 651 22.0 0.504 <0.001 
1There were no (P>0.05) Treatment x Time interactions 
2Scc = somatic cell count 
a,bMeans within a row with a different superscript differ (P <0.05).
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Table 4 Mean plasma metabolite and mineral concentration, and hepatic triacylglycerol 
concentrations in dairy cows offered diets that contained no added cobalt (C), added dietary 
Co (DC), added dietary vitamin B12 (DB) or injected vitamin B12 (IB) 
 Treatment P-value1 
  C DC DB IB SED Treatment Time 
Metabolites2    
 Glucose (mmol/l) 3.52 3.39 3.48 3.54 0.107 0.480 <0.001 
  3-OHB (mmol/l) 0.48 0.52 0.51 0.51 0.030 0.598 <0.001 
  NEFA (mmol/l) 0.40 0.40 0.41 0.44 0.054 0.848 <0.001 
  Urea (mmol/l) 4.36 4.24 4.29 4.27 0.214 0.953 <0.001 
Minerals   
  P (mmol/l) 3.01 3.18 3.19 3.19 0.141 0.519 <0.001 
  Mg (mmol/l) 0.86 0.79 0.90 0.73 0.133 0.582 0.611 
  Fe (µmol/l) 37.5 35.9 39.7 36.8 2.05 0.294 <0.001 
  Zn (µmol/l) 12.4ab 13.5b 12.8ab 11.6a 0.59 0.023 <0.001
  Cu (µmol/l) 14.5 15.1 14.9 15.0 0.70 0.863 <0.001
  Co (µmol/l2) 0.014 
±0.0022 
0.018 
±0.0022
0.015 
±0.0022
0.019 
±0.0022
<0.001 0.045 
  Se (µmol/l) 1.04 1.03 1.04 1.04 0.031 0.965 <0.001 
  Mo (µmol/l) 0.25 0.23 0.24 0.25 0.025 0.817 <0.001 
Hepatic triacylglycerol, mg/g fresh3      
  Pre-partum 5.81 
±2.349 
5.85 
±2.349 
5.56 
±2.349 
7.23 
±2.349  
0.616 -- 
  Post-partum 16.1 
±2.651 
18.4 
±2.651
22.0 
±2.651
19.3 
±2.651
0.862 -- 
1There were no (P>0.05) Treatment x Time interactions
23-OHB = ß-hydroxybutyrate, NEFA = non-esterified fatty acids 
3Data were not normally distributed and were analysed by firstly converting to natural log. 
The antiln least square means along with the interval of confidence at 95% are presented. 
a,b,cMeans within a row with a different superscript differ (P <0.05). 
 
 
 
 
27 
 
Table 5 Diet digestibility (kg/kg) of DM, organic matter (OM), nitrogen (N) and fibre in dairy 
cows offered diets that contained no added cobalt (C), added dietary Co (DC), added 
dietary vitamin B12 (DB) or injected vitamin B12 (IB) 
 Treatment   
  C DC DB IB SED P-value 
DM 0.71 0.72 0.73 0.73 0.016 0.630 
OM 0.73 0.74 0.74 0.75 0.015 0.631 
N 0.66 0.67 0.66 0.69 0.019 0.240 
NDF 0.54 0.53 0.58 0.56 0.029 0.257
ADF 0.45 0.45 0.50 0.48 0.031 0.234 
Hemicellulose1 0.68 0.65 0.73 0.70 0.031 0.136 
1Calculated as NDF-ADF 
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Table 6 Milk fatty acid profile during week 7 of lactation in dairy cows offered diets that 
contained no added cobalt (C), added dietary Co (DC), added dietary vitamin B12 (DB) 
or injected vitamin B12 (IB) 
 C DC DB IB SED P-value 
Fatty acid (g/100g)   
C4:0 4.87 4.78 4.94 4.42 0.322 0.401 
C6:0 2.77 2.66 2.62 2.67 0.099 0.356 
C8:0 1.56 1.33 1.34 1.60 0.124 0.066 
C10:0 3.27 3.01 2.64 3.22 0.170 0.164
C12:0 3.68 3.44 3.32 3.62 0.190 0.242 
C14:0 10.7 10.4 10.1 10.6 0.353 0.366 
C14:1 cis-9 0.87 0.94 0.89 0.90 0.079 0.817 
C15:0 0.99ab 0.93a 0.94ab 1.09b 0.056 0.025
C16:0 27.5 27.6 27.1 27.9 0.671 0.651
C16:1 cis-9 1.42 1.61 1.58 1.50 0.121 0.383 
C17:0 0.53 0.55 0.51 0.58 0.028 0.150 
C18:0 7.83 7.96 7.57 7.40 0.352 0.393 
C18:1 trans 6 to 8 0.40 0.41 0.39 0.38 0.047 0.936
C18:1 trans-9 0.30 0.36 0.35 0.31 0.057 0.692
C18:1 trans-10 0.61 0.54 0.67 0.73 0.104 0.323 
C18:1 trans-11 0.61 0.66 0.66 0.91 0.116 0.061 
C18:1 trans-12 0.53 0.60 0.66 0.48 0.091 0.222 
C18:1 cis-9 18.3 18.8 18.5 17.3 0.926 0.447
C18:2 cis-9, cis-12 2.53 2.41 2.40 2.48 0.124 0.686 
C18:2 cis-9, trans-11 0.56 0.62 0.56 0.56 0.069 0.769 
C18:2 trans-10, cis-12 0.03 0.05 0.05 0.05 0.008 0.221 
C18:3 cis-9, cis-12, cis-15 0.06 0.10 0.10 0.12 0.036 0.383 
C20:0 0.07 0.06 0.06 0.07 0.006 0.801
C20:1 cis-9 0.35 0.31 0.30 0.35 0.038 0.428 
C20:5 n-3 0.05 0.05 0.06 0.05 0.008 0.647 
C22:6 n-3 0.06 0.08 0.08 0.08 0.014 0.259 
Other 9.64 9.69 11.37 10.65 1.528 0.625 
Summation    
    Saturated 64.0 62.9 61.7 63.4 1.37 0.386 
    Monounsaturated 23.4 24.3 24.0 22.9 1.07 0.579 
    Polyunsaturated 3.30 3.32 3.30 3.37 0.181 0.984 
    <16 28.8 27.6 27.2 28.3 0.88 0.284
    16:0 and 16:1 29.0 29.4 28.8 29.5 0.70 0.693
     >16 32.9 33.6 33.0 31.9 1.33 0.651 
Desaturase index       
  14:1/(14:0+14:1) 0.07 0.08 0.08 0.08 0.005 0.475 
  16:1/(16:0+16:1) 0.05 0.06 0.06 0.05 0.004 0.264
  18:1/(18:0+18:1) 0.70 0.70 0.71 0.70 0.010 0.861
  c-9, t-11 CLA/( 18:1 t-11+   
  c-9, t-11 CLA1 
0.50b 0.51b 0.47ab 0.40a 0.033 0.006 
1CLA = conjugated linoleic acid.  
a,bMeans within a row with a different superscript differ (P <0.05). 
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Figure 1 Pre- and post-partum blood concentrations of vitamin B12 (a) and secondary 
metabolites, homocysteine (b), methylmalonic acid (c) and succinate (d). Cows offered diets 
that contained no added cobalt (Co; C: ), added dietary Co (DC: ●), added dietary vitamin 
B12 (DB: ○) or injected  vitamin B12 (IB: ). For plasma B12, interaction between Treatment and 
Time: P=0.007; SED = 22.7. For homocysteine, main effect of Time: P<0.001; SED = 0.265. 
For methylmalonic acid, interaction between Treatment x Time: P=0.033; SED = 0.031. For 
succinate, main effect of Time: P<0.001; SED = 0.231.  
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Added dietary cobalt or vitamin B12, or injecting vitamin B12 does not 
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Plasma vitamin B12 analysis was conducted using the ADIVA Centaur CP VB12 assay 
at the AHVLA laboratory, Shrewsbury, Shropshire, UK. The limit of detection was 33 
pmol/l, and coefficients of variation (CVs) for low, medium and high quality controls 
were 12.2, 12.4 and 12.4% respectively. Plasma homocysteine (Hcy) was determined 
using an Imola Auto analyser (RX imola; Randox Laboratories Ltd., Antrim, U.K.) using 
a kit supplied by Randox Laboratories (catalogue no. HY4036). The limit of detection 
was 1.74 µM and CV’s for low, medium and high quality controls were 1.03, 0.83 and 
0.95% respectively.  
Plasma methylmalonic acid (MMA) and succinic acid (SA) concentrations were 
determined by GC with mass spectroscopic detection (GC-MS) following derivatisation 
and extraction, modified from the method of Kanakkarambil et al. (2009).  Briefly, 50 
µl of plasma and 5 ul of internal standard (4-chlorobutyric acid (CBA) 250 µM) were 
added to 250 µl 12% BF3-methanol in a 2.5 ml screw capped glass vial, vortexed for 
30 s and heated at 95°C for 15 minutes on a heating block. After cooling, 250 µl 
distilled water and 250 µl dichloromethane (CH2Cl2) was added to the vial and vortexed 
for 30 s. The mixture was then centrifuged for 8 minutes at 2500 g at 4°C to separate 
the layers. The lower dichloromethane layer was transferred to a screw capped auto-
sampler vial with insert for GC-MS analysis. The method used a DB-WAX (crosslinked 
polyethylene glycol; J&W Scientific Agilent technology) 30 m long column of 0.25mm 
i.d and 0.15 µm film thickness. The carrier gas was He and flow rate was 1.0 ml/min. 
Injection mode was splitless and volume was 1 µl for both SCAN mode, for 
qualification, and SIM mode, for quantification. Injection port temperature was 260°C. 
The MS selective detector interference temperature was 280°C. The chromatograph 
was programmed for an initial temperature of 50C for 2 minutes, increased to 150C 
at 8C per minute, then increased to 220C at 100C per minute and held for 5 minutes 
at the final temperature. The MS was operated in electron impact (EI) ionization mode 
with the ionization energy of 70eV. SCAN mode measured at m/z: 20-500 and SIM 
(selected ion-monitoring) ions were set at 105 (for CBA), 115 (for MMA and SA). The 
same method was used for standards of MMA and SA at concentrations 0.156, 0.313, 
0.625, 1.25, 2.5, 5, 10 and 20 µmol/l. Calibration was carried out by comparison of 
peak areas of CBA with MMA and SA in the standards and the final results expressed 
in µmol/l plasma. The limit of detection and limit of quantification was 0.156 µmol/l. 
The CV’s for low, medium and high quality controls were 0.44, 1.03, 0.83% for MMA 
and 1.2, 1.1 and 2.3% for SA respectively.  
For hepatic triacylglycerol (TAG) analyses, samples were reduced to powder 
under liquid N, and known amounts (around 90-120 mg) weighed and homogenised 
in 1.6 ml of 0.47 M sodium sulphate, followed by the addition of 2 ml of 0.47 M sodium 
sulphate and 5.4 ml hexane:isopropanol (3:2, v/v). The mixtures were vortexed for 30 
s and centrifuged at 2000 g for 5 minutes at room temperature, then 2.5 ml of the top 
layer transferred to a glass tube and dried under nitrogen. The dried lipid was 
reconstituted in 1 ml of hexane and 10 or 60 µl transferred to a second tube and dried 
under nitrogen. Dried samples were then re-suspended in 120 µl of isopropanol and 
50 µl was mixed with 250 µl of colour reagent from Wako LabAssay triglyceride kit 
(Catalogue No. 290-63701; Alpha Laboratories, Hampshire, UK) for triacylglycerol 
measurement. Different concentrations of triolein standard (Catalogue No. T7140, 
Sigma-Aldrich, Gillingham, UK) were processed in parallel with liver samples to 
generate a standard curve. Different concentrations of glycerol and non-extracted 
triolein were included in each plate to monitor enzyme activity and completeness of 
lipolysis by lipoprotein lipase. In addition, a single liver analysed in each plate served 
as a quality control. The inter-assay CV was 8.4%.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 1 Plasma glucose (a), ß-hydroxybutyrate (3-OHB) (b), non esterified 
fatty acids (NEFA) (c) and urea (d) in pre- and post-partum of dairy cows offered diets that 
contained no added cobalt (Co) (C: ), added dietary Co (DC: ●), added dietary B12 (DB: ○) 
or injected  B12 (IB: ).  
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